Lower back pain is the single leading cause of years lived with disability globally — a finding confirmed by the Global Burden of Disease study and reported in the Lancet.1 In Australia, it affects approximately 70–80% of adults at some point in their life. It accounts for more healthcare expenditure and work absenteeism than almost any other musculoskeletal condition. And despite all of this, the most common responses to it — bed rest, early imaging, paracetamol, and passive treatments — are contradicted by the current evidence.

That gap between what the research shows and what actually happens in practice is partly a systems problem — clinical habits change slowly — and partly a communication problem. When a person presents with severe, debilitating back pain, telling them "movement is the best treatment" feels counterintuitive to both patient and clinician. But that is, overwhelmingly, what the evidence supports.

The Scale of the Problem

Hartvigsen and colleagues' landmark 2018 paper in the Lancet — part of a series on low back pain that represented the most comprehensive review of the condition ever published — described it as "a massive, growing, and largely under-appreciated global health problem." The authors noted that despite enormous increases in healthcare spending on back pain over the preceding two decades, rates of disability had not declined. The problem was not a lack of treatment — it was the wrong kind of treatment.2

The same series identified that 85–90% of lower back pain presentations are classified as "non-specific" — meaning no clear anatomical cause can be identified on clinical assessment or imaging. This does not mean there is no pain. It means the pain cannot be attributed to a specific, well-defined structural lesion. And it means that structural treatments (injections, surgery, passive manual therapy alone) are, for this large majority, unlikely to be the most effective approach.

Myths the Evidence Has Dismantled

Myth

You need to rest your back for it to heal. Staying off it prevents further damage.

Evidence

Prolonged rest worsens outcomes. Graded movement initiated early — within 1–2 days — is consistently superior to bed rest across RCTs and clinical guidelines.3

Myth

A disc bulge on MRI explains back pain and requires specific structural treatment.

Evidence

Disc abnormalities are present in ~30% of asymptomatic 20-year-olds and increase with age. MRI findings correlate poorly with pain and should not drive management in non-specific presentations.4

Myth

Paracetamol is effective for lower back pain and should be taken regularly.

Evidence

Williams et al's 2014 RCT in the Lancet found paracetamol was no better than placebo for acute LBP on any outcome measure — recovery time, pain, or disability.5

Myth

You should avoid bending, lifting, and exercise until the pain is fully gone.

Evidence

Avoiding movement reinforces fear-avoidance behaviour, which is one of the strongest predictors of chronicity. Progressive return to normal activities — including resistance exercise — is recommended in all major guidelines.3,6

The Biopsychosocial Model: Why Back Pain Is Never Just Physical

The dominant clinical model for understanding and managing lower back pain for the past three decades has been the biopsychosocial model, first comprehensively described for musculoskeletal pain by Waddell in the early 1990s and now so well supported that it underpins every major clinical guideline. The core insight is that biological factors (tissue, disc, joint) interact with psychological factors (fear, catastrophising, low mood) and social factors (work environment, social support, healthcare interactions) to determine both pain experience and recovery trajectory.

O'Sullivan, Caneiro, and colleagues, in their 2020 British Journal of Sports Medicine piece summarising key facts about back pain, emphasised that psychological and social factors are not merely contributors — they are often the primary drivers of why acute back pain transitions to chronic disability. Specifically, pain catastrophising (the tendency to interpret pain as threatening and uncontrollable) and kinesiophobia (fear of movement) are among the strongest predictors of poor outcomes, independent of pain intensity or structural findings.6

This does not mean back pain is "in your head." It means the brain's threat-assessment process — which is always involved in pain — can become calibrated toward excessive protection when the person believes their back is vulnerable, fragile, or structurally damaged beyond what the tissue state warrants. Unhelpful messages from clinicians ("your spine looks like that of a 70-year-old," "you have the back of a 20-year-old smoker") have measurable negative effects on pain outcomes and can directly contribute to the development of chronicity.

From Moseley (2007): "Understanding pain from a biopsychosocial perspective does not mean dismissing the tissue. It means that tissue state, nervous system state, and context all contribute to the pain experience — and effective treatment addresses all three." Moseley's work on reconceptualising pain has been influential in demonstrating that patient education about the neuroscience of pain is itself a therapeutic intervention, measurably reducing pain and improving function.7

What Does Work: The Evidence for Active Management

Foster, Anema, Cherkin, and colleagues' 2018 paper in the Lancet — the treatment-focused paper in the same series as Hartvigsen's review — synthesised the current evidence and provided clear recommendations. Their hierarchy for non-specific low back pain, based on evidence quality: first-line treatment should be reassurance, education about the benign nature of most back pain, advice to remain active, and supervised exercise.8

The American College of Physicians' 2017 clinical practice guideline, published in the Annals of Internal Medicine, provides similar recommendations: for acute and subacute LBP, superficial heat, spinal manipulation, massage, and acupuncture have evidence for short-term relief; for chronic LBP, exercise, multidisciplinary rehabilitation, cognitive behavioural therapy, mindfulness-based stress reduction, spinal manipulation, massage, and low-level laser therapy all have evidence of benefit. Opioids are recommended only when the benefits clearly outweigh the risks — and that threshold is rarely met in chronic non-specific LBP.9

The specific type of exercise matters less than most people assume. A 2017 Lancet review by Maher, Underwood, and Buchbinder concluded that no single exercise type has been shown to be clearly superior for non-specific LBP; what matters more is that exercise is progressive, that it is performed consistently, and that it is accompanied by education that addresses fear and encourages return to full activity.3

Red Flags: When Back Pain Does Require Urgent Investigation

While 85–90% of back pain is non-specific, a small proportion presents with features that warrant urgent assessment and imaging. These include: sudden onset of bilateral leg weakness or numbness, loss of bladder or bowel control (possible cauda equina syndrome — a medical emergency), systemic symptoms such as unexplained weight loss or fever, night pain that prevents sleep, history of cancer, or pain that is constant and worsening rather than variable with position and activity. These presentations require immediate medical referral — not musculoskeletal management alone.

For the vast majority of people — those with pain that is position-dependent, eased by movement, fluctuating, and without neurological deficit — the message from 30 years of rigorous research is consistent: keep moving, stay active, get help to address fear if it's present, and understand that the spine is more robust than most people believe.

Back pain that keeps coming back?

Ongoing, recurrent, or severe lower back pain benefits from a thorough assessment — to identify contributing factors, provide accurate education, and build a genuine rehabilitation plan. Book at Kenmore or Jindalee.

Book at Kenmore Book at Jindalee
References
  1. Vos T, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries: systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602.
  2. Hartvigsen J, Hancock MJ, Kongsted A, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356–2367.
  3. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.
  4. Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. American Journal of Neuroradiology. 2015;36(4):811–816.
  5. Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586–1596.
  6. O'Sullivan PB, Caneiro JP, O'Sullivan K, et al. Back to basics: 10 facts every person should know about back pain. British Journal of Sports Medicine. 2020;54(12):698–699.
  7. Moseley GL. Reconceptualising pain according to modern pain science. Physical Therapy Reviews. 2007;12(3):169–178.
  8. Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368–2383.
  9. Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2017;166(7):514–530.